BOGDAN NEDELESCU: Open Payments
NPI 1699732800 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,114 in 207 payments from 31 companies in 2025. Trend: 2023 $10,984 · 2024 $14,505 · 2025 $10,114
Food & beverage: $5,493Consulting: $4,050Travel & lodging: $459Education: $111
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 27 | $5,026 |
| AstraZeneca Pharmaceuticals LP | 19 | $698 |
| Teva Pharmaceuticals USA, Inc. | 17 | $573 |
| ABBVIE INC. | 17 | $490 |
| Otsuka America Pharmaceutical, Inc. | 13 | $421 |
| Neurocrine BioSciences, Inc. | 11 | $356 |
| Gilead Sciences, Inc. | 11 | $300 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $228 |
| Exact Sciences Corporation | 9 | $200 |
| Phathom Pharmaceuticals, Inc. | 10 | $190 |
Products named: KISUNLA, REXULTI, VRAYLAR, AIRSUPRA, INGREZZA, AUSTEDO XR, MOUNJARO, Kerendia.
Industry payments across MA — which companies pay providers there.
